NYSE:TFX - Teleflex Stock Price, Forecast & News

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex declared a quarterly dividend on Thursday, February 20th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.34 per share on Monday, March 16th. This represents a $1.36 annualized dividend and a dividend yield of 0.40%. The ex-dividend date of this dividend is Friday, February 28th. View Teleflex's Dividend History.

Teleflex Incorporated (NYSE:TFX) released its quarterly earnings results on Thursday, February, 20th. The medical technology company reported $3.28 earnings per share for the quarter, beating the Zacks' consensus estimate of $3.22 by $0.06. The medical technology company had revenue of $681 million for the quarter, compared to analysts' expectations of $679.01 million. Teleflex had a net margin of 17.78% and a return on equity of 18.97%. Teleflex's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.77 EPS. View Teleflex's Earnings History.

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Teleflex.

Teleflex updated its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of $12.50-12.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.68. The company issued revenue guidance of $2.764-2.790 billion, compared to the consensus revenue estimate of $2.78 billion.

10 brokers have issued twelve-month price objectives for Teleflex's shares. Their forecasts range from $378.00 to $450.00. On average, they expect Teleflex's stock price to reach $413.73 in the next year. This suggests a possible upside of 22.7% from the stock's current price. View Analyst Price Targets for Teleflex.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teleflex.

Media headlines about TFX stock have been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Teleflex earned a coverage optimism score of -4.2 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Teleflex.

Teleflex saw a drop in short interest during the month of February. As of February 14th, there was short interest totalling 606,200 shares, a drop of 5.0% from the January 30th total of 638,200 shares. Based on an average trading volume of 207,400 shares, the days-to-cover ratio is presently 2.9 days. Currently, 1.3% of the shares of the stock are sold short. View Teleflex's Current Options Chain.

Some companies that are related to Teleflex include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Steris (STE), Hologic (HOLX), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Alibaba Group (BABA), Visa (V), NVIDIA (NVDA), AbbVie (ABBV), Netflix (NFLX), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH), Lam Research (LRCX), ServiceNow (NOW) and ABIOMED (ABMD).

Teleflex's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (4.12%), Janus Henderson Group PLC (1.95%), Marshall Wace LLP (1.57%), Geode Capital Management LLC (1.56%), William Blair Investment Management LLC (1.48%) and Goldman Sachs Group Inc. (1.24%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View Institutional Ownership Trends for Teleflex.

TFX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Janus Henderson Group PLC, Rice Hall James & Associates LLC, Principal Financial Group Inc., Marshall Wace North America L.P., FIL Ltd and USS Investment Management Ltd. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell. View Insider Buying and Selling for Teleflex.

TFX stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Montag & Caldwell LLC, Scout Investments Inc., AMI Asset Management Corp, Lord Abbett & CO. LLC, Victory Capital Management Inc., Kornitzer Capital Management Inc. KS and Victory Capital Management Inc.. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer and John C Heinmiller. View Insider Buying and Selling for Teleflex.

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TFX stock can currently be purchased for approximately $337.10.

Teleflex has a market capitalization of $15.63 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 15,200 workers across the globe.View Additional Information About Teleflex.

The official website for Teleflex is http://www.teleflex.com/.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]